Physician profile
Farnaz Safi
NPI 1043528029
$1,027.85
in general payments reported to CMS, 2019-2025
24 companies · $396 in 2025
The $396 reported for 2025 was more than what 75% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $292 · 2020: $15.51 · 2021: $11.94 · 2022: $85.32 · 2023: $118 · 2024: $109 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $623.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $623.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $120.35 | 2019 | |
| Sumitomo Pharma America, INC. | $109.37 | 2023-2025 | Myfembree |
| Abbvie INC. | $98.10 | 2019-2024 | |
| Daiichi Sankyo INC. | $80.35 | 2019-2025 | Injectafer |
| Astellas Pharma US INC | $58.39 | 2024-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $55.61 | 2019-2025 | |
| Gynesonics, INC. | $48.36 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Hologic Sales and Service, LLC | $44.28 | 2025 | Novasure, Myosure Tissue Removal Device |
| Intuitive Surgical, INC. | $42.44 | 2025 | |
| Evofem Biosciences, INC. | $40.81 | 2023 | Phexxi |
| Coopersurgical, INC. | $39.21 | 2019-2023 | Paragard T 380a |
| Meditrina | $30.92 | 2022 | |
| Organon LLC | $30.73 | 2024-2025 | Jada System |
| Mayne Pharma Commercial LLC | $29.09 | 2025 | |
| Minerva Surgical, INC | $26.33 | 2021-2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $23.43 | 2019 | |
| Agile Therapeutics, INC. | $23.31 | 2023 | Twirla |
| Allotrope Medical, INC | $20.42 | 2022 | |
| Biogen, INC. | $20.28 | 2025 | Zurzuvae |
| Shield Therapeutics INC | $18.91 | 2025 | |
| Aroa Biosurgery Incorporated | $17.40 | 2025 | |
| Sage Therapeutics, LLC | $17.20 | 2023 | |
| Mylan Pharmaceuticals INC. | $17.05 | 2022 | |
| Merck Sharp & Dohme LLC | $15.51 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farnaz Safi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.